ArticleJournal of clinical practice and research2026
Oxidative Stress Biomarkers in Cerebral Palsy: Ischemia-Modified Albumin, Protein Carbonyl Compounds, AOPP, and Functional Status.
Article in Journal of clinical practice and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the relationship between oxidative stress markers, including ischemia-modified albumin (IMA), protein carbonyl compounds (PCC), and advanced oxidation protein products (AOPP), and functional status in children with cerebral palsy (CP). Materials and Methods: A total of 53 children aged 5-12 years diagnosed with CP and 28 age-matched healthy controls were included. Demographic and clinical characteristics, comorbidities, and the use of assistive devices were recorded after physical examination. Serum levels of IMA, PCC, and AOPP were measured in peripheral blood samples. Functional status was assessed using the Gross Motor Function Classification System (GMFCS). Correlations between GMFCS levels and oxidative stress markers were evaluated using Spearman's correlation analysis. Results: PCC and IMA levels were significantly higher in the CP group than in the control group (p<0.001 for both), whereas no significant difference was observed in AOPP levels (p=0.450). A statistically significant weak positive correlation was found between GMFCS levels and AOPP levels (rho=0.321, p=0.022). No significant correlations were observed between GMFCS levels and PCC, PCC protein, or IMA levels. Conclusion: IMA and PCC levels were elevated in children with CP compared with healthy controls. In addition, AOPP levels showed a weak but significant association with functional status. These findings indicate that certain oxidative stress-related biomarkers are elevated in children with CP, whereas AOPP levels show a weak association with functional severity. Further longitudinal studies are warranted to clarify the role of oxidative stress in disease progression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.